<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00363233</url>
  </required_header>
  <id_info>
    <org_study_id>04DZ14007</org_study_id>
    <nct_id>NCT00363233</nct_id>
  </id_info>
  <brief_title>The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes Mellitus</brief_title>
  <official_title>The Effects of Flax Lignans on Lipid Profile and Glucose Management in Type 2 Diabetes: a Randomized Double-Blind Cross-Over Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Academy of Sciences</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to improving the lipid profile and glucose control in type 2
      diabetic patients with supplementation of flax lignans. We hypothesize that flax lignans
      supplement will improve the cholesterol profile and glucose control in type 2 diabetic
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence of type 2 diabetes is increasing dramatically in the last decade in China.
      Hyperlipidemia is a comorbid condition in type 2 diabetes and increase the adverse health
      outcomes. Flax lignans, a phytoestrogen found in flaxseed is thought to be the compound
      responsible for cholesterol-lowering effect of flaxseed. Our purpose is to improving the
      lipid profile in type 2 diabetic patients with supplementation of flax lignans.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date>December 2006</completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total cholesterol at 3 months</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>LDL and triglycerides at 3 months; Blood glucose and HbA1C at 3 months</measure>
  </secondary_outcome>
  <enrollment>80</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Hypercholesterolemia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>flax lignans</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed type 2 diabetes

          -  Age: 50-79 years old

          -  LDL-cholesterol more than 2.9 mmol/l

        Exclusion Criteria:

          -  Current or previous (within 6 months) use of estrogen therapy

          -  Cancer

          -  Chronic gastrointestinal diseases

          -  Current use of antibiotics

          -  Any severe liver or renal diseases

          -  Systolic blood pressure more than 180 mmHg or phase 3 hypertension

          -  Any severe mental diseases

          -  Severe cardio- or cerebro-vascular diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xu Lin, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Nutritional Sciences, Chinese Academy of Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute for Nutritional Sciences, Chinese Academy of Sciences; Huadong Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200031</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2006</study_first_submitted>
  <study_first_submitted_qc>August 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2006</study_first_posted>
  <last_update_submitted>January 8, 2007</last_update_submitted>
  <last_update_submitted_qc>January 8, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 9, 2007</last_update_posted>
  <keyword>type 2 diabetes</keyword>
  <keyword>lignans</keyword>
  <keyword>flaxseed</keyword>
  <keyword>cholesterol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

